These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 31695766)

  • 21. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
    Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
    Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell Carcinoma.
    Zhang D; Wang Y; Hu X
    DNA Cell Biol; 2020 Oct; 39(10):1799-1812. PubMed ID: 32716214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma.
    Guo W; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang M; Wang G; Chen WQ; Guo L; Lu RQ; Zhou CH; Zhang X; Shi YH; Qiu SJ; Pan BS; Cao Y; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 May; 24(9):2203-2213. PubMed ID: 29374055
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
    Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
    Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
    Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
    Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bidirectional deep neural networks to integrate RNA and DNA data for predicting outcome for patients with hepatocellular carcinoma.
    Huang G; Wang C; Fu X
    Future Oncol; 2021 Nov; 17(33):4481-4495. PubMed ID: 34374301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple m
    Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
    BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
    Li J; Chen N; Gong X
    Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes.
    Chen W; Tang D; Ou M; Dai Y
    DNA Cell Biol; 2020 Apr; 39(4):499-512. PubMed ID: 32069130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.
    Villanueva A; Portela A; Sayols S; Battiston C; Hoshida Y; Méndez-González J; Imbeaud S; Letouzé E; Hernandez-Gea V; Cornella H; Pinyol R; Solé M; Fuster J; Zucman-Rossi J; Mazzaferro V; Esteller M; Llovet JM;
    Hepatology; 2015 Jun; 61(6):1945-56. PubMed ID: 25645722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation and gene expression profiling reveal potential association of retinol metabolism related genes with hepatocellular carcinoma development.
    Zhao Y; Wan K; Wang J; Wang S; Chang Y; Du Z; Zhang L; Dong L; Zhou D; Zhang W; Wang S; Yang Q
    PeerJ; 2024; 12():e17916. PubMed ID: 39193514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation site
    Yang Z; Chen W; Zhu H; Zhang L; Zhou K; Tang H; Sun R; Huang Y; Xie H; Zheng S; Jia C
    Future Oncol; 2022 Jun; 18(19):2401-2413. PubMed ID: 35502765
    [No Abstract]   [Full Text] [Related]  

  • 37.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
    World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
    Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
    Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
    Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H
    Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
    Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.